BRTX: Biorestorative Therapies Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Biorestorative Therapies Inc (BRTX).
$9.90M Market Cap.
BRTX Market Cap. (MRY)
BRTX Shares Outstanding (MRY)
BRTX Assets (MRY)
Total Assets
$12.28M
Total Liabilities
$3.75M
Total Investments
$10.18M
BRTX Income (MRY)
Revenue
$401.00K
Net Income
-$8.98M
Operating Expense
$11.93M
BRTX Cash Flow (MRY)
CF Operations
-$8.23M
CF Investing
$514.53K
CF Financing
$7.38M
BRTX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $12,279,799 (-2.63%) | $12,611,720 (-23.26%) | $16,434,691 (-26.81%) | $22,453,446 (416.52%) |
Assets Current | $11,144,221 (-2.16%) | $11,390,526 (-24.71%) | $15,128,490 (-29.53%) | $21,467,908 (573.61%) |
Assets Non-Current | $1,135,578 (-7.01%) | $1,221,194 (-6.51%) | $1,306,201 (32.54%) | $985,538 (-15.04%) |
Goodwill & Intangible Assets | $623,945 (-12.58%) | $713,692 (-11.17%) | $803,438 (36.24%) | $589,740 (-11.22%) |
Shareholders Equity | $8,531,393 (-14.72%) | $10,004,375 (-2.78%) | $10,290,339 (-52.35%) | $21,596,949 (1722.01%) |
Property Plant & Equipment Net | $362,936 (-28.49%) | $507,502 (0.94%) | $502,763 (27.03%) | $395,798 (-20.16%) |
Cash & Equivalents | $547,890 (-38.05%) | $884,377 (-48.40%) | $1,713,772 (-91.85%) | $21,026,727 (586.11%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $10,184,701 (0.03%) | $10,181,618 (-21.89%) | $13,035,636 (0%) | $0 (0%) |
Investments Current | $10,184,701 (0.03%) | $10,181,618 (-21.89%) | $13,035,636 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $188,400 (876.17%) | $19,300 (20.63%) | $16,000 (220.00%) | $5,000 (-70.59%) |
Trade & Non-Trade Payables | $483,070 (155.07%) | $189,389 (10.82%) | $170,902 (236.24%) | $50,827 (-57.23%) |
Accumulated Retained Earnings (Deficit) | -$155,678,715 (-6.12%) | -$146,699,334 (-7.64%) | -$136,281,630 (-1.59%) | -$134,146,128 (-49.31%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $162,317 (0.00%) | $162,317 (-70.58%) | $551,645 (-88.10%) |
Debt Current | $0 (0%) | $162,317 (0%) | $0 (0%) | $58,970 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $162,317 (-67.05%) | $492,675 (-89.37%) |
Total Liabilities | $3,748,406 (43.76%) | $2,607,345 (-57.57%) | $6,144,352 (617.38%) | $856,497 (-84.92%) |
Liabilities Current | $3,748,406 (43.76%) | $2,607,345 (-56.41%) | $5,982,035 (1544.22%) | $363,822 (-65.18%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $162,317 (-67.05%) | $492,675 (-89.37%) |
BRTX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $401,000 (175.03%) | $145,800 (21.70%) | $119,800 (160.43%) | $46,000 (-40.26%) |
Cost of Revenue | $28,072 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $6,579,413 (-41.94%) | $11,331,983 (-27.27%) | $15,580,473 (-39.20%) | $25,624,815 (1212.58%) |
Research & Development Expense | $5,348,709 (32.57%) | $4,034,591 (14.84%) | $3,513,352 (381.90%) | $729,058 (-16.85%) |
Operating Expenses | $11,928,122 (-22.38%) | $15,366,574 (-19.52%) | $19,093,825 (-27.55%) | $26,353,873 (831.54%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $1,815,366 (10.68%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$8,979,381 (13.81%) | -$10,417,704 (21.21%) | -$13,222,296 (70.16%) | -$44,303,295 (-293.01%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$8,979,381 (13.81%) | -$10,417,704 (21.21%) | -$13,222,296 (70.16%) | -$44,303,295 (-293.01%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$8,979,381 (13.81%) | -$10,417,704 (21.21%) | -$13,222,296 (70.16%) | -$44,303,295 (-293.01%) |
Weighted Average Shares | $7,763,932 (84.05%) | $4,218,347 (16.60%) | $3,617,858 (204.60%) | $1,187,741 (200.92%) |
Weighted Average Shares Diluted | $7,763,932 (84.05%) | $4,218,347 (16.60%) | $3,617,858 (204.60%) | $1,187,741 (200.92%) |
Earning Before Interest & Taxes (EBIT) | -$8,979,381 (13.81%) | -$10,417,704 (21.21%) | -$13,222,296 (68.88%) | -$42,487,929 (-341.09%) |
Gross Profit | $372,928 (155.78%) | $145,800 (21.70%) | $119,800 (160.43%) | $46,000 (-40.26%) |
Operating Income | -$11,555,194 (24.08%) | -$15,220,774 (19.78%) | -$18,974,025 (27.88%) | -$26,307,873 (-855.93%) |
BRTX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $514,529 (-84.18%) | $3,252,043 (124.27%) | -$13,399,855 (-43607.53%) | -$30,658 (0%) |
Net Cash Flow from Financing | $7,379,330 (214.18%) | $2,348,773 (0%) | $0 (0%) | $21,322,683 (324.15%) |
Net Cash Flow from Operations | -$8,230,346 (-27.99%) | -$6,430,211 (-8.75%) | -$5,913,100 (-77.58%) | -$3,329,908 (-69.52%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$336,487 (59.43%) | -$829,395 (95.71%) | -$19,312,955 (-207.52%) | $17,962,117 (486.43%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $620,718 (-81.87%) | $3,423,086 (126.41%) | -$12,959,632 (0%) | $0 (0%) |
Capital Expenditure | -$106,189 (37.92%) | -$171,043 (35.51%) | -$265,223 (-765.10%) | -$30,658 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $250,000 (-95.47%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $2,348,773 (0%) | $0 (0%) | $21,072,683 (210626.83%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $2,812,566 (-63.86%) | $7,782,967 (-38.29%) | $12,612,862 (-45.42%) | $23,108,955 (3240.89%) |
Depreciation Amortization & Accretion | $340,503 (32.98%) | $256,048 (-8.77%) | $280,667 (36.81%) | $205,152 (35.00%) |
BRTX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 93.00% (-7.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -2239.20% (68.66%) | -7145.20% (35.26%) | -11037.00% (88.54%) | -96311.50% (-557.87%) |
EBITDA Margin | -2154.30% (69.09%) | -6969.60% (35.48%) | -10802.70% (88.25%) | -91919.10% (-646.56%) |
Return on Average Equity (ROAE) | -82.00% (4.09%) | -85.50% (-6.74%) | -80.10% (95.38%) | -1734.90% (-1961.48%) |
Return on Average Assets (ROAA) | -59.00% (23.87%) | -77.50% (-9.46%) | -70.80% (87.53%) | -567.70% (-10.38%) |
Return on Sales (ROS) | -2239.20% (68.66%) | -7145.20% (35.26%) | -11037.00% (88.05%) | -92365.10% (-638.34%) |
Return on Invested Capital (ROIC) | -99.80% (5.49%) | -105.60% (60.54%) | -267.60% (74.84%) | -1063.60% (-626.50%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.23 (-75.14%) | -0.7 (6.51%) | -0.75 (-549.14%) | -0.12 (87.99%) |
Price to Sales Ratio (P/S) | 27.69 (-45.00%) | 50.34 (-39.38%) | 83.05 (-25.89%) | 112.06 (-20.79%) |
Price to Book Ratio (P/B) | 1.16 (41.64%) | 0.82 (-16.60%) | 0.98 (39.89%) | 0.7 (541.51%) |
Debt to Equity Ratio (D/E) | 0.44 (68.20%) | 0.26 (-56.28%) | 0.6 (1392.50%) | 0.04 (100.94%) |
Earnings Per Share (EPS) | -1.16 (53.04%) | -2.47 (32.33%) | -3.65 (90.21%) | -37.3 (-30.60%) |
Sales Per Share (SPS) | 0.05 (48.57%) | 0.04 (6.06%) | 0.03 (-15.38%) | 0.04 (-80.00%) |
Free Cash Flow Per Share (FCFPS) | -1.07 (31.37%) | -1.56 (8.37%) | -1.71 (39.63%) | -2.83 (43.16%) |
Book Value Per Share (BVPS) | 1.1 (-53.67%) | 2.37 (-16.60%) | 2.84 (-84.36%) | 18.18 (639.08%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.5 (-46.79%) | 2.82 (-34.71%) | 4.32 (-76.53%) | 18.41 (97.30%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.98 (-71.58%) | -0.57 (-97.92%) | -0.29 (39.87%) | -0.48 (41.73%) |
Asset Turnover | 0.03 (136.36%) | 0.01 (83.33%) | 0.01 (0.00%) | 0.01 (-82.86%) |
Current Ratio | 2.97 (-31.95%) | 4.37 (72.76%) | 2.53 (-95.71%) | 59.01 (1834.66%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$8,336,535 (-26.29%) | -$6,601,254 (-6.85%) | -$6,178,323 (-83.85%) | -$3,360,566 (-71.09%) |
Enterprise Value (EV) | $8,448,454 (45.79%) | $5,795,110 (55.44%) | $3,728,093 (-81.59%) | $20,254,900 (159.76%) |
Earnings Before Tax (EBT) | -$8,979,381 (13.81%) | -$10,417,704 (21.21%) | -$13,222,296 (70.16%) | -$44,303,295 (-293.01%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$8,638,878 (14.99%) | -$10,161,656 (21.48%) | -$12,941,629 (69.39%) | -$42,282,777 (-345.99%) |
Invested Capital | $7,359,558 (-14.11%) | $8,568,623 (5.81%) | $8,097,763 (690.18%) | $1,024,802 (-75.64%) |
Working Capital | $7,395,815 (-15.80%) | $8,783,181 (-3.97%) | $9,146,455 (-56.66%) | $21,104,086 (885.15%) |
Tangible Asset Value | $11,655,854 (-2.04%) | $11,898,028 (-23.88%) | $15,631,253 (-28.51%) | $21,863,706 (493.67%) |
Market Capitalization | $9,895,484 (20.83%) | $8,189,565 (-18.94%) | $10,102,480 (-33.36%) | $15,159,555 (7042.14%) |
Average Equity | $10,956,431 (-10.05%) | $12,180,336 (-26.22%) | $16,509,242 (546.51%) | $2,553,580 (121.10%) |
Average Assets | $15,230,898 (13.25%) | $13,448,520 (-28.00%) | $18,678,812 (139.36%) | $7,803,626 (256.05%) |
Invested Capital Average | $8,999,548 (-8.75%) | $9,862,993 (99.60%) | $4,941,302 (23.69%) | $3,994,840 (-39.28%) |
Shares | 6,919,919 (47.02%) | 4,706,917 (28.13%) | 3,673,629 (5.17%) | 3,492,985 (45322.43%) |